LBT 5.56% 1.7¢ lbt innovations limited

Ann: US FDA 510k Submitted for APAS Independence, page-25

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 19 Posts.
    lightbulb Created with Sketch. 46

    I do not think we need to concern ourselves to much with the current share price.

    Under the guise of don't commit to anything and surprise to the upside.... what would one expect really.

    The shareholders have nothing to go by really so the boredom leads to exhaustion and that leads to selling out in anger, probably.


    So we must try to determine for ourselves what the immediate future holds, thats why IMHO I expect the following over the next 4 months.


    • Dr Labor completes APAS Independence evaluation.Clinical trial commences for MRSA Module
    • 4 New sales to large Australia Lab
    • LBT concludes APAS Clinical Trial program with Successful results in its Melbourne and German trial achieving a 98% sensitivity in its detection of disease-causing bacteria.
    • 2 new sales to Dr Labor
    • 510k Supplement submitted for MRSA module
    • Further sales of APAS Independence
    • FDA Approval granted for APAS Independence as a Class two medical device
    • Dr Labor to present at the 29th ECCMID "Image interpretation of MRSA cultures using APAS Independence


    My Biggest concern was the potential for more capital raises but now I realize I have little to fear given the performance of the last 4 capital raises under the current CEO


    2nd December 2016

    7 million raised at 0.31 with the issue of 22,600,000 shares with11,300,000 options at 0.44

    Shareholders that participated are down $ 5,243,200 and the optionswere cancelled.     FAIL


    7th July 2017

    500,000 raised in SPP placement at 0.26 to eligible shareholdersThey are down $ 350,000   FAIL


    27th October 2017

    2 million raised at 0.31 Issued 6,451,613 shares to Autobio plus freeattaching Options of 3,255,806 at 0.44

    Autobio are down $1,535,483 and the options were cancelled. FAIL

    Theyprobably don’t mind because they were given the rights to Previ Isola whereaswe invested north of ten million to develop it LOL 


    6th March 2018

    7.9 Million raised at 0.15 with the issue of 46.8 million shares

    Shareholders that participated are down $ 3,369,600 and options werecancelled FAIL


    These are all BIG percentage losses, VERY BIG losses

    So really the company has got to get sales now because no one in their right or sane mind would give them anymore money.


    I have brought


    IMHO




 
watchlist Created with Sketch. Add LBT (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
-0.001(5.56%)
Mkt cap ! $23.13M
Open High Low Value Volume
1.8¢ 1.8¢ 1.7¢ $13.20K 747.0K

Buyers (Bids)

No. Vol. Price($)
4 776749 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 238095 1
View Market Depth
Last trade - 16.10pm 26/11/2024 (20 minute delay) ?
LBT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.